DALK-AD with big bubble effective

Article

Deep anterior lamellar keratoplasties by air dissection (DALK-AD) using the big bubble (BB) technique provides good visual outcomes in keratoconus treatment.

Deep anterior lamellar keratoplasties by air dissection (DALK-AD) using the big bubble (BB) technique provides good visual outcomes in keratoconus treatment, reveals a study in Cornea.

Dr David Smadja et al., National Reference Centre for Keratoconus, Bordeaux University Hospital, France, performed 44 consecutive keratoplasties on 42 keratoconus patients between January 2008 to June 2010. The team analysed the outcomes of the DALK-AD that wasn't converted to penetrating keratoplasty and a learning curve was created to achieve DALK-AD using BB.

Of the DALK-AD procedures performed, 32 were successful and 12 were converted to penetrating keratoplasty during the surgical procedure. At 12 months follow-up mean best-corrected logarithm of the minimum angle of resolution visual acuity was 0.88 ± 0.14.

Best-corrected visual acuity of ≥20/30 was seen in 93.3% of patients and 100% achieved best-corrected visual acuity of ≥20/40. At six and twelve months follow-up the mean gain of visual acuity in logarithm of the minimum angle of resolution lines was 6.12 ± 3.97 and 6.94 ± 4.18, respectively.

The DALK-AD with BB is a safe and effective technique for the surgical treatment of keratoconus. However, surgeons will need a learning period to reduce intraoperative complications.

The abstract for this investigation can be found here .

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.